Deborah H. Charych

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Kaitlyn Arsenault, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Deborah H. Charych:

Company Role Class Num Shares Value Price $ Report Date Ownership
Skye Bioscience, Inc. Director Stock Option (Right to Buy) 35,000 $1,190 $0.0170 24 Feb 2025 Direct

Insider Reports Filed by Deborah H. Charych

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SKYE Skye Bioscience, Inc. 24 Feb 2025 1 $0 4 Director 26 Feb 2025, 17:41
SKYE Skye Bioscience, Inc. 28 Oct 2024 1 $0 4 Director 30 Oct 2024, 20:25
SKYE Skye Bioscience, Inc. 29 Feb 2024 1 $0 4 Director 04 Mar 2024, 18:02
SKYE Skye Bioscience, Inc. 06 Nov 2023 1 $0 4 Director 06 Nov 2023, 20:30
SKYE Skye Bioscience, Inc. 25 Aug 2023 1 $0 4 Director 29 Aug 2023, 19:02
SKYE Skye Bioscience, Inc. 01 Mar 2023 0 $0 3/A Director 03 Mar 2023, 11:05
SKYE Skye Bioscience, Inc. 14 Feb 2023 0 $0 3 Director 16 Feb 2023, 16:36
SKYE Skye Bioscience, Inc. 14 Feb 2023 1 $0 4 Director 16 Feb 2023, 16:30